Administration time-dependent effects of raloxifen in postmenopausal women with osteoporosis.
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2013
At a glance
- Drugs Raloxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
- 30 Jul 2012 Additional lead trial centre added as reported by University Hospital Medical Information Network - Japan record.
- 30 Jul 2012 Actual end date (30 Jul 2012) added as reported by University Hospital Medical Information Network - Japan record.